MG1+IRF5-siRNA

N/A

Report date: 2026/04/07 14:22:45
NME

Base Information

Drug NameMG1+IRF5-siRNA
Drug Alias NameGene therapy (Daiichi Sankyo and Shiga University of Medical Science)MG2+IRF5-siRNA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate
Mechanisms of ActionInterferon regulatory factor 5 inhibitors
TargetsInterferon regulatory factor 5
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShiga University Of Medical ScienceDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A